Crenshaw B J,Jones L B,Bell C R, et al. Perspective on adenoviruses: epidemiology, pathogenicity and gene therapy[J]. Bio Mid, 2019, 7(61):1-18.
[10]
黄国虹,许文波.腺病毒新型别的研究进展[J].病毒学报,2013,29(3): 342-348.
[11]
Chen M,Zhu Z,Huang F,et al.Adenoviruses associated with acute respiratory diseases reported in Beijing from 201l to 2013[J].PLoS One,2015,10(3):e0121375.
[12]
Yoon H, Jhun B W, Kim H, et al.Characteristics of adenovirus pneumonia in Korean Military Personnel, 2012-2016[J]. J Korean Med Sci,2017. 32(2): 287-295.
[13]
Heo J Y, Lee J E, Kim H K,et al. Acute lower respiratory tract infections in soldiers, South Korea, April 2011-March 2012[J]. Emerg Infect Dis,2014, 20(5):875-877.
[14]
Kuschner R A, Russell K L, Abuja M, et al. A phase 3,randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S.military recruits[J].Vaccine,2013,31(4):2963-2971.
Hoke C H Jr, Snyder C E Jr. History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (adenovirus vaccine) in the context of the Department of Defense acquisition system[J]. Vaccine,2012, 31(12):1623-1632.
2020, Vol. 31 
